INHIBITION AND METABOLITE COMPLEXATION OF RAT HEPATIC-MICROSOMAL CYTOCHROME-P450 BY TRICYCLIC ANTIDEPRESSANTS

被引:42
作者
MURRAY, M
FIELD, SL
机构
[1] Liver Research Unit, Department of Medicine, University of Sydney, Westmead
关键词
D O I
10.1016/0006-2952(92)90163-D
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Administration of imipramine (IMIP) and other tricyclic antidepressants to humans and experimental animals has been associated with inhibition of hepatic cytochrome P450 (P450)-mediated drug oxidation. This study investigated the capacity of several structurally related tricyclic antidepressants to inhibit microsomal P450 activity in vitro. It was found that IMIP, desipramine (DES), amitriptyline (AMIT) and nortriptyline (NOR) were poor inhibitors of P450 activity unless they were preincubated with microsomes and NADPH prior to transfer to flasks containing substrate. Thus, subsequent experiments characterized the time-dependent intensification of inhibition produced by the drugs. Preincubation of the N-methylaminoalkyl agents DES and NOR (200-mu-M) with NADPH-supplemented microsomes for 30 min led to an approximate 30% decrease in spectrally apparent P450 content; the N,N-dimethylaminoalkyl drugs IMIP and AMIT did not significantly decrease apparent P450 content. Analysis of optical difference spectra of microsomes during NADPH-mediated metabolism of these drugs revealed a prominent increase in absorbance at 454 nm with DES and NOR but not IMIP or AMIT. Monospecific antibodies to the male-specific P450 2C11 and, to a lesser extent, P450 3A2 were effective in preventing the formation of the DES metabolite 454 nm-Soret peak. In addition, the 454 nm absorbance was not produced by the incubation of DES with NADPH-fortified hepatic microsomes from adult female or immature male rats. Studies with the steroid substrate testosterone, which undergoes P450-specific positional hydroxylation, indicated that P450 2C11-mediated 2-alpha- and 16-alpha-hydroxylation were most susceptible to the time-dependent intensification of inhibition produced by DES (8.5 and 7.0 min preincubation required for loss of 50% activity, respectively) and NOR (4.0 and 4.0 min for loss of 50% of both activities). The 6-beta- (P450 3A2) and 7-alpha-hydroxylase (P450 2A1) pathways were somewhat less susceptible to inhibition than 2-alpha- and 16-alpha-hydroxylation. These findings suggest that DES and NOR form a metabolite intermediate (MI)-complex, characterized by a Soret region absorbance maximum near 454 nm in the optical difference spectrum, with microsomal P450 in male rat liver in vitro. Studies with the steroid substrate testosterone as well as immunoinhibition experiments are consistent with the proposition that this MI complex forms principally with the male-specific enzymes P450 2C11 and 3A2. Although a human orthologue of P450 2C11 has not yet been identified, P450s of the 3A subfamily are quantitatively important enzymes in human liver. MI complexation of such enzymes could be a feasible underlying mechanism for certain clinically important drug interactions involving tricyclic antidepressants.
引用
收藏
页码:2065 / 2071
页数:7
相关论文
共 29 条
[1]   INHIBITION OF ALFENTANIL METABOLISM BY ERYTHROMYCIN [J].
BARTKOWSKI, RR ;
GOLDBERG, ME ;
LARIJANI, GE ;
BOERNER, T .
CLINICAL PHARMACOLOGY & THERAPEUTICS, 1989, 46 (01) :99-102
[2]   SPECTRAL INTERACTION OF ORPHENADRINE AND ITS METABOLITES WITH OXIDIZED AND REDUCED HEPATIC-MICROSOMAL CYTOCHROME-P-450 IN THE RAT [J].
BAST, A ;
NOORDHOEK, J .
BIOCHEMICAL PHARMACOLOGY, 1982, 31 (17) :2745-2753
[3]  
BICKEL MH, 1968, ARCH INT PHARMACOD T, V173, P433
[4]   ROLE OF P450IID6, THE TARGET OF THE SPARTEINE-DEBRISOQUIN OXIDATION POLYMORPHISM, IN THE METABOLISM OF IMIPRAMINE [J].
BROSEN, K ;
ZEUGIN, T ;
MEYER, UA .
CLINICAL PHARMACOLOGY & THERAPEUTICS, 1991, 49 (06) :609-617
[5]   DOWN-REGULATION OF THE MALE-SPECIFIC HEPATIC-MICROSOMAL STEROID 16-ALPHA-HYDROXYLASE, CYTOCHROME P-450UT-A, IN RATS WITH PORTAL BYPASS - RELEVANCE TO ESTRADIOL ACCUMULATION AND IMPAIRED DRUG-METABOLISM IN HEPATIC CIRRHOSIS [J].
CANTRILL, E ;
MURRAY, M ;
MEHTA, I ;
FARRELL, GC .
JOURNAL OF CLINICAL INVESTIGATION, 1989, 83 (04) :1211-1216
[6]  
DANAN G, 1981, J PHARMACOL EXP THER, V218, P509
[7]   THE EFFECT OF ANTIDEPRESSANTS ON ETHYLMORPHINE AND IMIPRAMINE N-DEMETHYLATION IN RAT-LIVER MICROSOMES [J].
DANIEL, W ;
MELZACKA, M .
JOURNAL OF PHARMACY AND PHARMACOLOGY, 1986, 38 (05) :396-398
[8]   INHIBITION OF METABOLISM OF N-SUBSTITUTED AMPHETAMINES BY SKF 525-A AND RELATED COMPOUNDS [J].
FRANKLIN, MR .
XENOBIOTICA, 1974, 4 (03) :143-150
[9]   SUSPECTED INTERACTION - WARFARIN AND ERYTHROMYCIN [J].
HASSELL, D ;
UTT, JK .
SOUTHERN MEDICAL JOURNAL, 1985, 78 (08) :1015-1016
[10]  
LOWRY OH, 1951, J BIOL CHEM, V193, P265